Pioneering bone marrow transplantation – Led by Nobel Prize recipient Dr. E. Donnall Thomas, Fred Hutch researchers have transformed bone marrow transplantation into standard treatment for CML and other blood cancers. The procedure, as well as its sister treatment stem cell transplantation, is one of cancer treatment's greatest success stories. Bone marrow transplantation has saved hundreds of thousands of lives. Learn more >
Developing and improving drug treatments – Fred Hutch participated in clinical trials that led to the FDA approval of the "leukemia pill," Gleevec®.
Hutch investigators continue studying Gleevec to determine which CML patients are best treated with the drug and which treatments may work well in conjunction with the drug. In addition, the center contributed to the FDA approval of "second generation" tyrosine kinase inhibitors known as nilotinib and dasatinib.
Using the immune system to fight cancer – Dr. Stanley Riddell and colleagues are investigating use of a treatment technique for leukemia called immunotherapy—harnessing the body's own infection-fighting T-cells against the disease. The approach holds promise for treating several types of cancer, including chemotherapy-resistant ALL in children. Learn more >